These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18250047)

  • 1. [Detection of multidrug resistance-associated proteins MRP2, MRP3, and MRP5 mRNA expressions in hepatocarcinoma cells using SYBR real-time PCR].
    Zhang L; Fang CH; Fan YF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):219-21. PubMed ID: 18250047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells.
    Wang XB; Wang SS; Zhang QF; Liu M; Li HL; Liu Y; Wang JN; Zheng F; Guo LY; Xiang JZ
    Oncol Rep; 2010 Jan; 23(1):211-5. PubMed ID: 19956884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
    Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
    Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
    Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
    Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
    Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
    Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
    Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M
    Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
    Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
    Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
    Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
    J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS.
    Donner MG; Warskulat U; Saha N; Häussinger D
    Biol Chem; 2004; 385(3-4):331-9. PubMed ID: 15134348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells.
    Hagmann W; Jesnowski R; Faissner R; Guo C; Löhr JM
    Pancreatology; 2009; 9(1-2):136-44. PubMed ID: 19077464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins.
    Wakamatsu T; Nakahashi Y; Hachimine D; Seki T; Okazaki K
    Int J Oncol; 2007 Dec; 31(6):1465-72. PubMed ID: 17982673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.
    Steinbach D; Lengemann J; Voigt A; Hermann J; Zintl F; Sauerbrey A
    Clin Cancer Res; 2003 Mar; 9(3):1083-6. PubMed ID: 12631611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
    Yan F; Wang XM; Pan C
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract.
    Zimmermann C; Gutmann H; Hruz P; Gutzwiller JP; Beglinger C; Drewe J
    Drug Metab Dispos; 2005 Feb; 33(2):219-24. PubMed ID: 15523049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas.
    Rau S; Autschbach F; Riedel HD; Konig J; Kulaksiz H; Stiehl A; Riemann JF; Rost D
    Eur J Clin Invest; 2008 Feb; 38(2):134-42. PubMed ID: 18226047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.
    Young LC; Campling BG; Voskoglou-Nomikos T; Cole SP; Deeley RG; Gerlach JH
    Clin Cancer Res; 1999 Mar; 5(3):673-80. PubMed ID: 10100721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids.
    Pułaski L; Kania K; Ratajewski M; Uchiumi T; Kuwano M; Bartosz G
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):229-34. PubMed ID: 15979871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells.
    Pascolo L; Fernetti C; Pirulli D; Crovella S; Amoroso A; Tiribelli C
    Biochem Biophys Res Commun; 2003 Mar; 303(1):259-65. PubMed ID: 12646196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia.
    Plasschaert SL; de Bont ES; Boezen M; vander Kolk DM; Daenen SM; Faber KN; Kamps WA; de Vries EG; Vellenga E
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8661-8. PubMed ID: 16361551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
    Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
    Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.